top of page
DC.jpg

IN THE STATES

WASHINGTON, D.C.

The economic footprint of the biopharmaceutical industry can be measured by traditional indicators of employment and output, and its impact on the vendors, large and small, that provide services or supplies to America's biopharmaceutical research companies. The data below illustrates jobs and  economic impact data, clinical trial data, and vendor/supplier data from 16 biopharmaceutical companies regarding their business relationships with vendors and the total expenditures paid to vendors in Washington, D.C.

DC.png

Economic
Output

$1.7B

Direct Jobs Supported by the Industry

2,064

Total Jobs Supported

5,160

State Total Vendor Relationships

1,001

State Total Vendor Spending

$427,644,102

Total Clinical
Trials

294

Dollar Amount Invested

$63.3M

Clinical Trial Participants

4,433

Total Economic Impact

$106.9M

bottom of page